Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

GFour Productions Presents The Musical®: The Survivor Tour® benefiting Susan G. Komen® in 14 Cities During Breast Cancer Awareness Month This October
  • USA - English


News provided by

Bohlsen Group

Sep 22, 2015, 07:10 ET

Share this article

Share toX

Share this article

Share toX


Laughter truly is the best medicine!

Post this

Fort Lauderdale, Fla. (PRWEB) September 22, 2015 -- GFour Productions, winner of 44 Tony Awards and 54 Drama Desk Awards, has proudly joined forces with Susan G. Komen® to launch Menopause The Musical®: The Survivor Tour® benefiting Susan G. Komen® in the fall of 2015. The show that has brought joy to millions of women is turning laughter into the best medicine. With a cast of breast cancer survivors and co-survivors, Menopause The Musical and Komen partner to offer inspiration, sisterhood and hope. During the month of October, designated as National Breast Cancer Awareness Month, The Survivor Tour® will come to 14 cities across the country and will donate no less than $2 per ticket sold to Komen to further its mission to save lives and end breast cancer.

The tour will also be on the road during World Menopause Day on Sunday, October 18 with a performance in Hartford, Ct.

The Survivor Tour® is proud to fundraise for Komen, which since 1982 has invested more than $2.6 billion in research, screening, treatment, education and support programs for people affected by breast cancer.

“Menopause The Musical has lifted the spirits of more than 11 million people worldwide, and we are thrilled to be part of this extraordinary mission with GFour and a cast that represents the more than 3.1 million breast cancer survivors in the U.S.,” said Komen President and CEO Judy Salerno, M.D., M.S. “Their support makes a difference in the lives of women and men, and helps us move closer to our vision of a world without breast cancer.”

The Survivor Tour® October dates include:
• Charlotte, N.C. – October 1-3, Blumenthal Performing Arts Center McGlohon Theater at Spirit Square
• Columbia, S.C. – October 4, The Township Auditorium
• Greensboro, N.C. – October 6-7, Carolina Theatre
• Pembroke, N.C. – October 9, The Paul R. Givens Performing Arts Center
• North Charleston, S.C. – October 10, North Charleston Performing Arts Center
• Warren, Ohio – October 13, WD Packard Music Hall
• Greensburg, Pa. – October 14, Palace Theatre
• Hartford, Ct. – October 16-18, The Bushnell
• Burlington, Vt. – October 20, Flynn Center
• Plymouth, Mass. – October 22, Plymouth Memorial Hall
• Lexington, Mass. – October 23-25, Cary Hall
• Rutland, Vt. – October 28-29, Paramount Theatre
• Schnectady, N.Y. – October 30, Proctor’s Theatre
• Woonsocket, R.I. – October 31-November 1, Stadium Theatre Performing Arts Centre

For more than a decade, Menopause The Musical has worked to inspire and support women dealing with life after “The Change.” “Menopause has always been a cause-based show,” said Menopause The Musical Director Seth Greenleaf. “The cause was helping women see that what they are experiencing is perfectly normal, and that they are not alone. The Susan G. Komen® partnership increases the importance of our purpose because now we’re not just talking about life affirming, but life saving. We’re deeply proud to be a part of this effort.”

The Survivor Tour cast includes breast cancer co-survivor Linda Boston (Professional Woman) and survivors Teri Adams (Iowa Housewife), Judy Blue (Soap Star), and Megan Cavanagh (Earth Mother) known for her role as Marla Hooch in the 1992 film A League of Their Own. For more information on the cast and tour, visit https://www.youtube.com/watch?v=ygJ5NCiqK20&feature=youtu.be.

Menopause The Musical is set in a department store where four women at a lingerie sale have nothing in common but a black lace bra AND memory loss, hot flashes, night sweats, not enough sex, too much sex and more! Singing along to classic tunes from the ‘60s, ‘70s and ‘80s, the cast forms a sisterhood with the entire audience. Whether naturally occurring or being thrust into menopause as a result of cancer treatment, Menopause The Musical helps women embrace and celebrate that menopause is no longer “The Silent Passage.” For more information on the tour, please visit TheSurvivorTour.com.

“GFour Productions is happy to partner with Susan G. Komen® to raise important awareness, while proving that laughter truly is the best medicine,” said producer Kathi Glist.

Menopause The Musical is recognized as the longest-running scripted musical production in Las Vegas and continues to entertain nightly at Harrah’s. The hilarious musical has entertained audiences across the globe in more than 450 U.S. cities, nearly 300 international cities, and a total of 15 countries. For more information, visit http://www.MenopauseTheMusical.com.

# # #
About GFour Productions
GFour Productions (Producer) GFour Productions recent successes include winning the 2013 Tony Award® for their 50th anniversary production of Edward Albee's WHO’S AFRAID OF VIRGINIA WOOLF; Co-financing the 5 time Tony Award®, 5 time Drama Desk Award®, and 7 time Olivier Award® Winner for Best Musical, MATILDA THE MUSICAL; Producing the critically acclaimed revivals of THE GLASS MENAGERIE starring Cherry Jones and Zachary Quinto, and the history making production of LADY DAY AT EMERSON’S BAR AND GRILL starring 6 time Tony Award® winner, Audra McDonald; and the Pulitzer Prize winning play, DISGRACED, which The New York Times called, “Terrific, turbulent, and roaring to life with currents of dramatic electricity!” GFour recently premièred the Spanish-language version of their hit, MENOPAUSIA EL MUSICAL, in Hollywood, CA, and have now begun the international launch of their ever popular MENOPAUSE brand, bringing laughter to audiences around the world. They began producing in 1981 with NINE, winning the Tony Award® that year for Best Musical. Among their favorite Broadway productions are MY ONE AND ONLY starring Tommy Tune, ZORBA THE GREEK starring Anthony Quinn, THE RINK starring Liza Minnelli, BABY, GRAND HOTEL, GRIND, BIG, TRUE WEST, the original and the revival of LA CAGE AUX FOLLES which won them Tony Awards for Best Musical in 1983 and Best Revival in 2004. Their combined shows have been nominated for 115 Tony Awards®, winning 44 and 110 Drama Desk Awards®, winning 56. For more information, please visit GFourProductions.com

About Susan G. Komen®
Susan G. Komen is the world’s largest breast cancer organization, funding more breast cancer research than any other nonprofit while providing real-time help to those facing the disease. Since its founding in 1982, Komen has funded more than $847 million in research and provided $1.8 billion in funding to screening, education, treatment and psychosocial support programs serving millions of people in more than 30 countries worldwide. Komen was founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at ww5.komen.org/social.

Andy Wilson, Bohlsen Group, +1 (317) 602-7137, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.